| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |